Atlas Trials

Resectable Pancreatic Adenocarcinoma

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Resectable Pancreatic Adenocarcinoma

RecordFirmDate
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286)M.D. Anderson Cancer Center2021-09-28
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer (NCT04927780)Erasmus Medical Center2021-09-07
Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma (NCT04915417)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2021-08-01
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334)National Cancer Institute (NCI)2021-06-22
A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma (NCT05066802)Yonsei University2020-05-11
Intraoperative Radiation Therapy for Resectable Pancreatic Cancer (NCT03273374)Gangnam Severance Hospital2017-08-14
Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer (NCT03251365)Hospital General de Ciudad Real2017-07-27
Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma (NCT00600002)Edward Nelson2004-06-01

Track Resectable Pancreatic Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.